Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group

1. Provencio, M. ¹
2. Cruz Mora, M.A. ²
3. Gómez-Codina, J. ³
4. Quero Blanco, C. ⁴
5. Llanos, M. ⁵
6. García-Arroyo, F.R. ⁶
7. De La Cruz, L. ⁷
8. Gumá Padró, J. ⁸
9. Delgado Pérez, J.R. ⁹
10. Sánchez, A. ¹
11. Álvarez Cabellos, R. ²
12. Rueda, A. ¹⁰